Literature DB >> 19564763

Up-regulation in receptor for advanced glycation end-products in inflammatory circumstances in bovine coccygeal intervertebral disc specimens in vitro.

Tatsuhiro Yoshida1, Jin Soo Park, Kimiaki Yokosuka, Kotaro Jimbo, Kei Yamada, Kimiaki Sato, Masayoshi Takeuchi, Sho-Ichi Yamagishi, Kensei Nagata.   

Abstract

STUDY
DESIGN: This study investigated whether or not the receptor for advanced glycation end-products (RAGE) was up-regulated in inflammatory circumstances and consequently associated with aggrecan content in nucleus pulposus in vitro.
OBJECTIVE: To investigate the activation of AGEs-RAGE complex by the irritation of IL-1beta in bovine intervertebral disc (IVD). SUMMARY OF BACKGROUND DATA: Although we have demonstrated that the accumulation of AGEs contributed to disc degeneration in human, it may be that acceleration in the AGEs-RAGE complex might be more important, mediated by expression levels of RAGE that increase in inflammatory mediators including IL-1beta in some tissues. Therefore, we investigated, in this study, the correlation if any between IL-1beta and AGEs-RAGE complex in bovine IVD.
METHODS: Samples of bovine coccygeal IVDs were harvested (n = 6). The presence of AGEs and RAGE were identified by immunohistochemistry. Real-time polymerase chain reaction (PCR) was used to quantify the messenger RNA levels of aggrecan after 6 days' stimulation of AGEs. Real-time PCR and immunofluorescein cytochemistry were performed to analyze the expression of RAGE after 2 days' stimulation of IL-1beta. The aggrecan expressions were evaluated by real-time PCR after 2 days' stimulation of combination of AGEs and/or IL-1beta.
RESULTS: Immunohistochemical analysis revealed that AGEs and RAGE were localized within the bovine IVDs. AGEs significantly decreased the aggrecan expression in bovine IVD as in human IVD. The RAGE expression was significantly increased by 2 days' stimulation of IL-1beta. The aggrecan expression was decreased by stimulated AGEs and IL-1beta together, although not decreased by stimulated AGEs or IL-1beta separately.
CONCLUSION: This is the first report to show the correlation between IL-1beta and AGEs-RAGE complex in IVD. Our results suggested that the increased RAGE expression in inflammatory circumstances and interaction with AGEs are risk factors in decreasing of aggrecan content in nucleus pulposus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564763     DOI: 10.1097/BRS.0b013e3181a98390

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  9 in total

1.  AGEs induce ectopic endochondral ossification in intervertebral discs

Authors:  S Illien-Jünger; O M Torre; W F Kindschuh; X Chen; D M Laudier; J C Iatridis
Journal:  Eur Cell Mater       Date:  2016-11-18       Impact factor: 3.942

2.  Chronic ingestion of advanced glycation end products induces degenerative spinal changes and hypertrophy in aging pre-diabetic mice.

Authors:  Svenja Illien-Jünger; Young Lu; Sheeraz A Qureshi; Andrew C Hecht; Weijing Cai; Helen Vlassara; Gary E Striker; James C Iatridis
Journal:  PLoS One       Date:  2015-02-10       Impact factor: 3.240

3.  Exosomes from mesenchymal stem cells modulate endoplasmic reticulum stress to protect against nucleus pulposus cell death and ameliorate intervertebral disc degeneration in vivo.

Authors:  Zhiwei Liao; Rongjin Luo; Gaocai Li; Yu Song; Shengfeng Zhan; Kangcheng Zhao; Wenbin Hua; Yukun Zhang; Xinghuo Wu; Cao Yang
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

4.  TNF-α induces up-regulation of MicroRNA-27a via the P38 signalling pathway, which inhibits intervertebral disc degeneration by targeting FSTL1.

Authors:  Jie Shi; Shaoyi Wang; Qiting He; Kaiwen Liu; Wei Zhao; Qing Xie; Lei Cheng
Journal:  J Cell Mol Med       Date:  2021-06-30       Impact factor: 5.310

5.  Complications in the spine associated with type 2 diabetes: The role of advanced glycation end-products.

Authors:  Kaitlyn Broz; Remy E Walk; Simon Y Tang
Journal:  Med Nov Technol Devices       Date:  2021-03-02

6.  Combined anti-inflammatory and anti-AGE drug treatments have a protective effect on intervertebral discs in mice with diabetes.

Authors:  Svenja Illien-Junger; Fabrizio Grosjean; Damien M Laudier; Helen Vlassara; Gary E Striker; James C Iatridis
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

Review 7.  Update on the pathophysiology of degenerative disc disease and new developments in treatment strategies.

Authors:  Adam H Hsieh; S Tim Yoon
Journal:  Open Access J Sports Med       Date:  2010-10-14

Review 8.  Disk degeneration and low back pain: are they fat-related conditions?

Authors:  Dino Samartzis; Jaro Karppinen; Jason Pui Yin Cheung; Jeffrey Lotz
Journal:  Global Spine J       Date:  2013-07-17

9.  Upregulation of miR-107 expression following hyperbaric oxygen treatment suppresses HMGB1/RAGE signaling in degenerated human nucleus pulposus cells.

Authors:  Chi-Chien Niu; Song-Shu Lin; Li-Jen Yuan; Meng-Ling Lu; Steve W N Ueng; Chuen-Yung Yang; Tsung-Ting Tsai; Po-Liang Lai
Journal:  Arthritis Res Ther       Date:  2019-01-31       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.